Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development | News
Search Refinements

Drug Discovery & Development News

View news from other Pharmaceutical sectors:
91-105 of 4257 results
Aptinyx raises $65m for neurological disorder drugs
By PBR Staff Writer
US-based biopharmaceutical firm Aptinyx has raised $65m in Series A financing to advance therapies for neurological disorders.
Drug Research > Drug Discovery & Development > News
MGB Biopharma holds pre-IND meeting with FDA on MGB-BP-3 development program
MGB Biopharma has held a pre-Investigational New Drug (pre-IND) meeting with the Food and Drug Administration (FDA) to discuss the regulatory strategy for the development programme of MGB-BP-3 in the US.
Drug Research > Drug Discovery & Development > News
Gates Foundation gives $38m grant to Takeda for polio eradication
By PBR Staff Writer
The Bill & Melinda Gates Foundation is providing a $38m grant to Takeda Pharmaceutical to support polio eradication in developing countries.
Drug Research > Drug Discovery & Development > News
Ariad Pharmaceuticals agrees to sell European operations to Incyte
By PBR Staff Writer
Ariad Pharmaceuticals has agreed to sell its European operations and out-license the commercial rights to Iclusig in Europe to the US-based biopharmaceutical firm Incyte.
Drug Research > Drug Discovery & Development > News
ACT Genomics raises $12.5m in series B funding
ACT Genomics, an integrated cancer molecular information company that transforms precision cancer care, has raised $12.5m in Series B funding.
Drug Research > Drug Discovery & Development > News
Immunovaccine launches DPX-NEO program to develop patient-specific neoepitope immunotherapies
Immunovaccine has launched its DPX-NEO program to develop neoepitope immunotherapies to further expand the immuno-oncology applications for its DepoVax-based vaccines.
Drug Research > Drug Discovery & Development > News
Sirnaomics raises $10m to fund clinical development of anti-fibrosis programs
Sirnaomics, a biopharmaceutical company in discovery and development of RNAi therapeutics, has closed Series B financing of $10m.
Drug Research > Drug Discovery & Development > News
Ergomed to acquire Haemostatix
By PBR Staff Writer
Drug development services provider Ergomed has announced the proposed acquisition of University of Leicester spin-out firm Haemostatix for about £28m.
Drug Research > Drug Discovery & Development > News
Graybug Vision secures $44.5m funding for clinical development activities
By PBR Staff Writer
Venture-stage pharmaceutical firm Graybug Vision has secured $44.5m in funding for clinical development activities.
Drug Research > Drug Discovery & Development > News
Ablynx announces milestone in drug discovery collaboration with Novartis
Ablynx has received an undisclosed milestone payment from its collaboration with Novartis.
Drug Research > Drug Discovery & Development > News
Cumberland Pharmaceuticals unveils new program to develop Vasculan for systemic sclerosis
Cumberland Pharmaceuticals has unveiled a new program to develop Vasculan for systemic sclerosis.
Drug Research > Drug Discovery & Development > News
X-Chem achieves milestone in drug discovery collaboration with Alexion Pharmaceuticals
X-Chem has achieved a milestone in its drug discovery collaboration with Alexion Pharmaceuticals, triggering a payment to X-Chem.
Drug Research > Drug Discovery & Development > News
Zymeworks, GSK enter second collaboration to develop bi-specific antibodies
Zymeworks has entered into a new licensing agreement with GSK for the research, development, and commercialization of novel bi-specific antibodies enabled using Zymeworks’ Azymetric drug discovery platform.
Drug Research > Drug Discovery & Development > News
NewLink Genetics wins $21.6m contract option from BARDA for Ebola vaccine development
NewLink Genetics announced that the Biomedical Advanced Research and Development Authority (BARDA) of the United States Department of Health and Human Services (HHS) has exercised its $21.6m option to support continued development of the investigational rVSV-ZEBOV-GP (Ebola) vaccine candidate.
Drug Research > Drug Discovery & Development > News
hVIVO, SEEK to work together to develop vaccines against Flu and Zika infections
By PBR Staff Writer
hVIVO has unveiled a joint venture (JV) investment with the SEEK Group for the development of vaccines against influenza and mosquito-borne diseases like the Zika virus and other flaviviruses.
Drug Research > Drug Discovery & Development > News
91-105 of 4257 results